Revelstone Capital Acquisition Corp. Class A Common Stock

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P 500 also rose, gaining, 0.26% to 4,701.05. Check This Out: Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace'   Leading and Lagging Sectors   Communication services shares jumped by 0.3% on Friday. In trading on Friday, consumer staples shares fell by 0.8%.   Top Headline   Constellation Brands Inc (NYSE: STZ) posted upbeat earnings for its third quarter, while sales missed estimates. Constellation Brands reported third-quarter FY24 net sales growth of 1.4% year-on-year to $2.47 billion, missing the analyst consensus of $2.54 billion. Comparable EPS of $3.19 beat the consensus estimate of $3.00. Constellation cut FY24 reported EPS outlook from $9.60 - $9.80 to $9.15 - $9.35. The company raised FY24 operating cash flow forecast from $2.4 billion - $2.6 billion to $2.6 billion - $2.8 billion and free cash flow outlook from $1.2 billion - $1.3 billion to $1.4 billion - $1.5 billion.   Equities Trading UP   AxoGen, Inc. (NASDAQ: AXGN) shares shot up 24% to $8.40 as the company reported preliminary unaudited revenue for fourth quarter and full-year 2023. The company also said President and Chief Executive Officer Karen Zaderej plans to retire from the Company by Jan. 2025. Shares of Banzai International, Inc. (NASDAQ: BNZI) got a boost, surging 66% to $2.76. Banzai International signed a non-binding letter of intent to acquire ...

Related tickers: AGL, MPW, STZ, AXGN, APLT, RCAC, BNZI.

Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of progression to overt heart failure. The study's primary endpoint was stabilization or improvement in cardiac functional capacity as measured by Peak VO2 in patients treated with AT-001 1500mg twice daily (BID) compared to placebo. Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Ainos, Inc.(NASDAQ: AIMD) jumped 112.6% to $3.6805 after falling more than 12% on Thursday. Revelstone Capital Acquisition Corp. (NASDAQ: RCAC) shares climbed 89.6% to $10.71. Revelstone Capital Acquisition cancelled special meeting to approve business combination with Set Jet, Inc. Banzai International, Inc. (NASDAQ: BNZI) surged 74% to $2.92. Banzai International signed a non-binding letter of intent to acquire IGLeads, a cutting-edge automated lead generation platform. Safe and Green Development Corporation (NASDAQ: SGD) shares rose 56.5% to $2.1307. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform. NexImmune, Inc. (NASDAQ: NEXI) gained 30% to $7.67 Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose climbed 27.8% to $0.78 after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Polished.com Inc. (NYSE: POL) gained 27.2% to $8.05. Swvl Holdings Corp. (NASDAQ: SWVL) gained 27.2% to $2.90. PolyPid Ltd. (NASDAQ: PYPD) gained 25% to $8.44. PolyPid announced $16.2 million private placement of 3,371,312 shares at $4.81 per share. AxoGen, Inc. (NASDAQ: AXGN) jumped 20.4% to $8.13 as the company reported ...

Related tickers: VYGR, RCAC, JG, SMFL, ATXI, SWVL, ANGO, ALLO, INBS, CPRX, VERB, LSDI, CYCC, PTON, SGD, AGL, APLT, PNST, GBX, KRUS, BNZI, MPW, POL, CISO, SBR, PYPD, KORE, IMCR, ELAN, NEXI, AXGN, AIMD, EXAI, OMGA, DYN, DRMA, TBPH, SABS.